Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTA in Type 2 Diabetes and Dyslipidemia
NCT00605787Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Jan 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tetradecylthioacetic acid in type 2 diabetes mellitus (T2DM) and dyslipidemia, sponsored by Haukeland University Hospital. Primary endpoint: Plasma lipids at 28 days. Started Jan 2002; status: completed.
02
Drugs
tetradecylthioacetic acid
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on NCT00605787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605787.